Jinli M. Han
107. W. Yanjiang Road
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Metabolic CRISPR screening identifies RPE as a key regulator of acquired enzalutamide resistance through FKBP5 destabilization in prostate cancer.
Journal: Oncogene
Published: May 02, 2026
DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 31, 2026
Predicting Survival in Patients with Neuroendocrine Prostate Cancer: A SEER-Based Comprehensive Study.
Journal: The world journal of men's health
Published: March 07, 2024
A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.
Journal: Frontiers in oncology
Published: December 12, 2021
Selection of Optimal Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Clear Cell Renal Cell Carcinoma: A Predictive Model Based on SEER Database.
Journal: Frontiers in oncology
Published: November 13, 2021
A Model for Identifying Optimal Patients for Primary Tumor Resection in Patients With Metastatic Bladder Cancer.
Journal: Frontiers in oncology
Published: November 05, 2021
Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 14, 2021
Corrigendum to "Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM." [Canc. Lett. 449 (2019) 31-44].
Journal: Cancer letters
Published: January 04, 2021
A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer.
Journal: Molecular cancer
Published: January 31, 2019
Last Updated: 09/26/2026